Teleflex Incorporated 10-K Summary: Fiscal Year Ended December 30, 2001
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 30, 2001. Teleflex Incorporated is a diversified manufacturer of precision mechanical and electronic controls, medical devices, and aerospace components. The company operates through three primary segments: Commercial (automotive, marine, industrial), Medical (invasive devices, surgical instruments), and Aerospace (cargo handling, turbine engine services). The company employs approximately 17,600 people and operates roughly 150 facilities globally.
Key Financial Metrics
The provided filing text incorporates the consolidated financial statements by reference to the 2001 Annual Report to Shareholders; therefore, specific values for revenue, net income, cash flow, margins, and debt are not explicitly stated in this document. However, the following data points are available:
- Market Capitalization: Approximately $1.59 billion (aggregate market value of voting stock held by non-affiliates as of February 1, 2002).
- Shares Outstanding: 38,958,059 common shares (as of February 1, 2002).
- Allowance for Doubtful Accounts: Ended the year at $9,004,000 (up from $5,776,000 in 2000).
- Backlog (Firm Orders):
- Aerospace: $287 million (vs. $303 million in 2000).
- Medical: $33 million (vs. $28 million in 2000).
- Commercial: $156 million (vs. $139 million in 2000).
Material Changes and Segment Performance
Market Mix (2001 Net Sales): Commercial (48%), Aerospace (30%), and Medical (22%).
Acquisitions and Expansion:
- Commercial: Acquired Morse Controls (Feb 2001) for marine/truck markets and the Fluid Handling Division of McKechnie Vehicle Components (July 2001) for automotive fluid transfer.
- Medical: Acquired Medical Marketing Group (2000) for homecare catheters.
- Aerospace: Acquired Air Cargo Equipment Corporation (2000) and Turbine Technology Services Corporation (2000) to expand cargo and turbine repair capabilities.
Backlog Trends: The Aerospace backlog decreased slightly year-over-year, while Commercial and Medical backlogs increased. Management anticipates over half of the Aerospace backlog will be filled in 2002, with substantially all Medical and Commercial backlog filled in 2002.
Outlook, Risks, and Management Commentary
Strategy: The company continues to utilize its "New Venture Fund" (0.5% of sales) to foster innovation and entrepreneurial risk-taking in new product development.
Risks and Contingencies:
- Environmental: Named as a Potentially Responsible Party (PRP) at various EPA sites. Management does not expect environmental costs to be material to financial position.
- Legal: Subject to normal business litigation; no pending claims expected to have a material effect.
- Competition: Competitive position relies on technical competence and engineering capabilities rather than patent protection.
Guidance: Specific forward-looking financial guidance is not provided in this text; investors are referred to the "2001 Financial Review" in the Annual Report to Shareholders.
Investor Verification Checklist
- Verify specific revenue, net income, and cash flow figures in the 2001 Annual Report to Shareholders (pages 17-31), as these are incorporated by reference and not listed in this 10-K text.
- Review the "Liquidity, Market Risk and Capital Resources" section (pages 26-30 of the Annual Report) for detailed debt and liquidity analysis.
- Confirm the impact of recent acquisitions (Morse Controls, McKechnie Fluid Handling) on 2002 segment margins.
- Monitor the execution of the $287 million Aerospace backlog, noting the slight decline from the prior year.
- Assess the status of environmental liabilities at sites where the company is named a Potentially Responsible Party.